Pricing Log in Create free account
Friday 6 November 2026 Export IRTC’s income statement to Excel — free account

iRhythm Holdings, Inc.

IRTC Healthcare Medical Devices

iRhythm Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $747.1 million, up 26.2% from fiscal 2024.

Revenue
+14.9%
EPS
−462.5%
Free cash flow
−157.6%
Total debt
+0.48%

Quarter to September 2026, against a year earlier

89.98 40.21 −30.89%
Market cap
$4.3B
P/E
0.0×
Fwd P/E
−311×
Dividend yield
—
F-score
5/9
Altman Z
4.02
Beneish M
−3.04
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

iRhythm Holdings, Inc. (IRTC) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, iRhythm Holdings, Inc. (IRTC) trades at a EV/EBITDA of 2,944×. Over the past ten years it has ranged from 0.0× (June 2026) to 3,025× (November 2026); the current reading is higher than 100% of that period. That is above the Medical Devices industry median of 11.5× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 0.0× —
FY2024 0.0× —
FY2023 0.0× —
FY2022 0.0× —
FY2021 0.0× —
FY2020 0.0× —
FY2019 0.0× —
FY2018 0.0× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 2,577× (3.00%)
Jun 2026 2,656× —
Mar 2026 0.0× —
Dec 2025 0.0× —
40 more quarters

Against its own ten years

Low 0.0× High 3,025×
Ten-year median 0.0×
Current reading's percentile 100

EV/EBITDA against peers

Company EV/EBITDA
AXGN AxoGen, Inc. compare n/m
TXG 10x Genomics compare n/m
LIVN LivaNova PLC compare 17.6×
ITGR Integer Holdings Corporation compare 18.8×
UFPT UFP Technologies, Inc. compare 20.5×
TMDX TransMedics Group, Inc. compare 22.0×
HAE Haemonetics Corporation compare 23.6×
NEOG Neogen Corporation compare 27.2×
IRTC iRhythm Holdings, Inc. 2,944×
Medical Devices industry median 11.5×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on IRTC